Autolomous Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
41
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.38M
- Investors
-
7
Autolomous General Information
Description
Developer of a healthcare manufacturing data management platform intended to support the development and delivery of advanced medicines. The company offers laboratory-friendly software that securely transfers manufacturing data to a cloud-based system with immutable data tracking, scheduling tools, and digital quality approvals, enabling therapy developers to manage manufacturing processes efficiently and improve the accessibility of advanced medicines.
Contact Information
Website
www.autolomous.comCorporate Office
- 2 Bloomsbury Place
- London WC1A 2QA
- England, United Kingdom
Corporate Office
- 2 Bloomsbury Place
- London WC1A 2QA
- England, United Kingdom
Autolomous Timeline
Autolomous Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 01-Mar-2025 | $4.38M | Completed | Generating Revenue | ||
| 7. Angel (individual) | 29-Sep-2024 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 29-May-2024 | Completed | Generating Revenue | |||
| 5. Grant | 12-Jun-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 27-Dec-2022 | Completed | Generating Revenue | |||
| 3. Grant | 01-Apr-2021 | Completed | Generating Revenue | |||
| 2. Grant | 04-Jan-2021 | $269K | $852K | Completed | Generating Revenue | |
| 1. Seed Round | 24-Jul-2020 | $852K | $852K | Completed | Generating Revenue |
Autolomous Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| C2 Preferred Ordinary | ||||||||
| C1 Preferred Ordinary | ||||||||
| B Ordinary | ||||||||
| B Ordinary | 3,831 | $0.013202 | $215.94 | $215.94 | 1x | $215.94 | 2.53% | |
| Ordinary | 11,337 | $0.013202 | $79.21 | $79.21 | 1x | $79.21 | 7.48% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Autolomous Signals
Autolomous Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| İstanbul Portföy Yönetimi | Asset Manager | Minority | ||
| BioTools Innovator | Accelerator/Incubator | Minority | ||
| MedTech Innovator | Accelerator/Incubator | |||
| Aescuvest | Venture Capital | Minority | ||
| Health Innovations | Venture Capital | Minority |
Autolomous FAQs
-
When was Autolomous founded?
Autolomous was founded in 2019.
-
Where is Autolomous headquartered?
Autolomous is headquartered in London, United Kingdom.
-
What is the size of Autolomous?
Autolomous has 41 total employees.
-
What industry is Autolomous in?
Autolomous’s primary industry is Other Healthcare Technology Systems.
-
Is Autolomous a private or public company?
Autolomous is a Private company.
-
What is Autolomous’s current revenue?
The current revenue for Autolomous is .
-
How much funding has Autolomous raised over time?
Autolomous has raised $12.4M.
-
Who are Autolomous’s investors?
İstanbul Portföy Yönetimi, BioTools Innovator, MedTech Innovator, Aescuvest, and Health Innovations are 5 of 7 investors who have invested in Autolomous.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process